Book contents
- Frontmatter
- Introduction
- Part I Medicine and Disease: An Overview
- Part II Changing Concepts of Health and Disease
- Part III Medical Specialties and Disease Prevention
- Part IV Measuring Health
- Part V The History of Human Disease in the World Outside Asia
- Part VI The History of Human Disease in Asia
- Part VII The Geography of Human Disease
- Part VIII Major Human Diseases Past and Present
- VIII.1 Acquired Immune Deficiency Syndrome (AIDS)
- VIII.2 African Trypanosomiasis (Sleeping Sickness)
- VIII.3 Ainhum
- VIII.4 Alzheimer’s Disease
- VIII.5 Amebic Dysentery
- VIII.6 Anemia
- VIII.7 Anorexia Nervosa
- VIII.8 Anthrax
- VIII.9 Apoplexy and Stroke
- VIII.10 Arboviruses
- VIII.11 Arenaviruses
- VIII.12 Arthritis (Rheumatoid)
- VIII.13 Ascariasis
- VIII.14 Bacillary Dysentery
- VIII.15 Beriberi
- VIII.16 Black Death
- VIII.17 Black and Brown Lung Disease
- VIII.18 Bleeding Disorders
- VIII.19 Botulism
- VIII.20 Brucellosis
- VIII.21 Bubonic Plague
- VIII.22 Carrión’s Disease
- VIII.23 Catarrh
- VIII.24 Cestode Infections
- VIII.25 Chagas’ Disease
- VIII.26 Chlorosis
- VIII.27 Cholera
- VIII.28 Cirrhosis
- VIII.29 Clonorchiasis
- VIII.30 Croup
- VIII.31 Cystic Fibrosis
- VIII.32 Cytomegalovirus Infection
- VIII.33 Dengue
- VIII.34 Diabetes
- VIII.35 Diarrheal Diseases (Acute)
- VIII.36 Diphtheria
- VIII.37 Down Syndrome
- VIII.38 Dracunculiasis
- VIII.39 Dropsy
- VIII.40 Dysentery
- VIII.41 Dyspepsia
- VIII.42 Ebola Virus Disease
- VIII.43 Echinococcosis (Hydatidosis)
- VIII.44 Eclampsia
- VIII.45 Emphysema
- VIII.46 Encephalitis Lethargica
- VIII.47 Enterobiasis
- VIII.48 Epilepsy
- VIII.49 Ergotism
- VIII.50 Erysipelas
- VIII.51 Fascioliasis
- VIII.52 Fasciolopsiasis
- VIII.53 Favism
- VIII.54 Filariasis
- VIII.55 Fungus Infections (Mycoses)
- VIII.56 Fungus Poisoning
- VIII.57 Gallstones (Cholelithiasis)
- VIII.58 Gangrene
- VIII.59 Giardiasis
- VIII.60 Glomerulonephritis (Bright’s Disease)
- VIII.61 Goiter
- VIII.62 Gonorrhea
- VIII.63 Gout
- VIII.64 Herpes Simplex
- VIII.65 Herpesviruses
- VIII.66 Histoplasmosis
- VIII.67 Hookworm Disease
- VIII.68 Huntington’s Disease (Chorea)
- VIII.69 Hypertension
- VIII.70 Infectious Hepatitis
- VIII.71 Infectious Mononucleosis
- VIII.72 Inflammatory Bowel Disease
- VIII.73 Influenza
- VIII.74 Japanese B Encephalitis
- VIII.75 Lactose Intolerance and Malabsorption
- VIII.76 Lassa Fever
- VIII.77 Lead Poisoning
- VIII.78 Legionnaires’ Disease
- VIII.79 Leishmaniasis
- VIII.80 Leprosy
- VIII.81 Leptospirosis
- VIII.82 Leukemia
- VIII.83 Lupus Erythematosus
- VIII.84 Lyme Borreliosis (Lyme Disease)
- VIII.85 Malaria
- VIII.86 Marburg Virus Disease
- VIII.87 Mastoiditis
- VIII.88 Measles
- VIII.89 Meningitis
- VIII.90 Milk Sickness (Tremetol Poisoning)
- VIII.91 Multiple Sclerosis
- VIII.92 Mumps
- VIII.93 Muscular Dystrophy
- VIII.94 Myasthenia Gravis
- VIII.95 Nematode Infections
- VIII.96 Onchocerciasis
- VIII.97 Ophthalmia (Conjunctivitis and Trachoma)
- VIII.98 Osteoarthritis
- VIII.99 Osteoporosis
- VIII.100 Paget’s Disease of Bone
- VIII.101 Paragonimiasis
- VIII.102 Parkinson’s Disease
- VIII.103 Pellagra
- VIII.104 Periodontal Disease (Pyorrhea)
- VIII.105 Pica
- VIII.106 Pinta
- VIII.107 Plague of Athens
- VIII.108 Pneumocystis Pneumonia (Interstitial Plasma Cell Pneumonia, Pneumocystosis)
- VIII.109 Pneumonia
- VIII.110 Poliomyelitis
- VIII.111 Protein-Energy Malnutrition
- VIII.112 Protozoan Infections
- VIII.113 Puerperal Fever
- VIII.114 Q Fever
- VIII.115 Rabies
- VIII.116 Relapsing Fever
- VIII.117 Rheumatic Fever and Rheumatic Heart Disease
- VIII.118 Rickets and Osteomalacia
- VIII.119 Rickettsial Diseases
- VIII.120 Rocky Mountain Spotted Fever and the Spotted Fever Group Diseases
- VIII.121 Rubella
- VIII.122 St. Anthony’s Fire
- VIII.123 Scarlet Fever
- VIII.124 Schistosomiasis
- VIII.125 Scrofula (Scrophula)
- VIII.126 Scurvy
- VIII.127 Sickle-Cell Anemia
- VIII.128 Smallpox
- VIII.129 Streptococcal Diseases
- VIII.130 Strongyloidiasis
- VIII.131 Sudden Infant Death Syndrome
- VIII.132 Sudden Unexplained Death Syndrome (Asian)
- VIII.133 Sweating Sickness
- VIII.134 Syphilis
- VIII.135 Syphilis, Nonvenereal
- VIII.136 Tapeworm
- VIII.137 Tay-Sachs Disease
- VIII.138 Tetanus
- VIII.139 Tetanus, Neonatal
- VIII.140 Tetany
- VIII.141 Toxoplasmosis
- VIII.142 Trematode Infections
- VIII.143 Trench Fever
- VIII.144 The Treponematoses
- VIII.145 Trichinosis
- VIII.146 Trichuriasis
- VIII.147 Tuberculosis
- VIII.148 Tularemia
- VIII.149 Typhoid Fever
- VIII.150 Typhomalarial Fever
- VIII.151 Typhus, Epidemic
- VIII.152 Typhus, Murine
- VIII.153 Typhus, Scrub (Tsutsugamushi)
- VIII.154 Urolithiasis (Renal and Urinary Bladder Stone Disease)
- VIII.155 Varicella Zoster
- VIII.156 Whooping Cough
- VIII.157 Yaws
- VIII.158 Yellow Fever
- Indexes
- References
VIII.4 - Alzheimer’s Disease
from Part VIII - Major Human Diseases Past and Present
Published online by Cambridge University Press: 28 March 2008
Edited by
Book contents
- Frontmatter
- Introduction
- Part I Medicine and Disease: An Overview
- Part II Changing Concepts of Health and Disease
- Part III Medical Specialties and Disease Prevention
- Part IV Measuring Health
- Part V The History of Human Disease in the World Outside Asia
- Part VI The History of Human Disease in Asia
- Part VII The Geography of Human Disease
- Part VIII Major Human Diseases Past and Present
- VIII.1 Acquired Immune Deficiency Syndrome (AIDS)
- VIII.2 African Trypanosomiasis (Sleeping Sickness)
- VIII.3 Ainhum
- VIII.4 Alzheimer’s Disease
- VIII.5 Amebic Dysentery
- VIII.6 Anemia
- VIII.7 Anorexia Nervosa
- VIII.8 Anthrax
- VIII.9 Apoplexy and Stroke
- VIII.10 Arboviruses
- VIII.11 Arenaviruses
- VIII.12 Arthritis (Rheumatoid)
- VIII.13 Ascariasis
- VIII.14 Bacillary Dysentery
- VIII.15 Beriberi
- VIII.16 Black Death
- VIII.17 Black and Brown Lung Disease
- VIII.18 Bleeding Disorders
- VIII.19 Botulism
- VIII.20 Brucellosis
- VIII.21 Bubonic Plague
- VIII.22 Carrión’s Disease
- VIII.23 Catarrh
- VIII.24 Cestode Infections
- VIII.25 Chagas’ Disease
- VIII.26 Chlorosis
- VIII.27 Cholera
- VIII.28 Cirrhosis
- VIII.29 Clonorchiasis
- VIII.30 Croup
- VIII.31 Cystic Fibrosis
- VIII.32 Cytomegalovirus Infection
- VIII.33 Dengue
- VIII.34 Diabetes
- VIII.35 Diarrheal Diseases (Acute)
- VIII.36 Diphtheria
- VIII.37 Down Syndrome
- VIII.38 Dracunculiasis
- VIII.39 Dropsy
- VIII.40 Dysentery
- VIII.41 Dyspepsia
- VIII.42 Ebola Virus Disease
- VIII.43 Echinococcosis (Hydatidosis)
- VIII.44 Eclampsia
- VIII.45 Emphysema
- VIII.46 Encephalitis Lethargica
- VIII.47 Enterobiasis
- VIII.48 Epilepsy
- VIII.49 Ergotism
- VIII.50 Erysipelas
- VIII.51 Fascioliasis
- VIII.52 Fasciolopsiasis
- VIII.53 Favism
- VIII.54 Filariasis
- VIII.55 Fungus Infections (Mycoses)
- VIII.56 Fungus Poisoning
- VIII.57 Gallstones (Cholelithiasis)
- VIII.58 Gangrene
- VIII.59 Giardiasis
- VIII.60 Glomerulonephritis (Bright’s Disease)
- VIII.61 Goiter
- VIII.62 Gonorrhea
- VIII.63 Gout
- VIII.64 Herpes Simplex
- VIII.65 Herpesviruses
- VIII.66 Histoplasmosis
- VIII.67 Hookworm Disease
- VIII.68 Huntington’s Disease (Chorea)
- VIII.69 Hypertension
- VIII.70 Infectious Hepatitis
- VIII.71 Infectious Mononucleosis
- VIII.72 Inflammatory Bowel Disease
- VIII.73 Influenza
- VIII.74 Japanese B Encephalitis
- VIII.75 Lactose Intolerance and Malabsorption
- VIII.76 Lassa Fever
- VIII.77 Lead Poisoning
- VIII.78 Legionnaires’ Disease
- VIII.79 Leishmaniasis
- VIII.80 Leprosy
- VIII.81 Leptospirosis
- VIII.82 Leukemia
- VIII.83 Lupus Erythematosus
- VIII.84 Lyme Borreliosis (Lyme Disease)
- VIII.85 Malaria
- VIII.86 Marburg Virus Disease
- VIII.87 Mastoiditis
- VIII.88 Measles
- VIII.89 Meningitis
- VIII.90 Milk Sickness (Tremetol Poisoning)
- VIII.91 Multiple Sclerosis
- VIII.92 Mumps
- VIII.93 Muscular Dystrophy
- VIII.94 Myasthenia Gravis
- VIII.95 Nematode Infections
- VIII.96 Onchocerciasis
- VIII.97 Ophthalmia (Conjunctivitis and Trachoma)
- VIII.98 Osteoarthritis
- VIII.99 Osteoporosis
- VIII.100 Paget’s Disease of Bone
- VIII.101 Paragonimiasis
- VIII.102 Parkinson’s Disease
- VIII.103 Pellagra
- VIII.104 Periodontal Disease (Pyorrhea)
- VIII.105 Pica
- VIII.106 Pinta
- VIII.107 Plague of Athens
- VIII.108 Pneumocystis Pneumonia (Interstitial Plasma Cell Pneumonia, Pneumocystosis)
- VIII.109 Pneumonia
- VIII.110 Poliomyelitis
- VIII.111 Protein-Energy Malnutrition
- VIII.112 Protozoan Infections
- VIII.113 Puerperal Fever
- VIII.114 Q Fever
- VIII.115 Rabies
- VIII.116 Relapsing Fever
- VIII.117 Rheumatic Fever and Rheumatic Heart Disease
- VIII.118 Rickets and Osteomalacia
- VIII.119 Rickettsial Diseases
- VIII.120 Rocky Mountain Spotted Fever and the Spotted Fever Group Diseases
- VIII.121 Rubella
- VIII.122 St. Anthony’s Fire
- VIII.123 Scarlet Fever
- VIII.124 Schistosomiasis
- VIII.125 Scrofula (Scrophula)
- VIII.126 Scurvy
- VIII.127 Sickle-Cell Anemia
- VIII.128 Smallpox
- VIII.129 Streptococcal Diseases
- VIII.130 Strongyloidiasis
- VIII.131 Sudden Infant Death Syndrome
- VIII.132 Sudden Unexplained Death Syndrome (Asian)
- VIII.133 Sweating Sickness
- VIII.134 Syphilis
- VIII.135 Syphilis, Nonvenereal
- VIII.136 Tapeworm
- VIII.137 Tay-Sachs Disease
- VIII.138 Tetanus
- VIII.139 Tetanus, Neonatal
- VIII.140 Tetany
- VIII.141 Toxoplasmosis
- VIII.142 Trematode Infections
- VIII.143 Trench Fever
- VIII.144 The Treponematoses
- VIII.145 Trichinosis
- VIII.146 Trichuriasis
- VIII.147 Tuberculosis
- VIII.148 Tularemia
- VIII.149 Typhoid Fever
- VIII.150 Typhomalarial Fever
- VIII.151 Typhus, Epidemic
- VIII.152 Typhus, Murine
- VIII.153 Typhus, Scrub (Tsutsugamushi)
- VIII.154 Urolithiasis (Renal and Urinary Bladder Stone Disease)
- VIII.155 Varicella Zoster
- VIII.156 Whooping Cough
- VIII.157 Yaws
- VIII.158 Yellow Fever
- Indexes
- References
Summary
In 1906, Alois Alzheimer first described a neurological disorder of the brain associated with global deterioration of cognitive functioning and resulting in severe social impairment. Once thought rare, senile dementia of the Alzheimer’s type is the most commonly acquired progressive brain syndrome. Alzheimer’s disease begins with insidious intellectual and memory loss as the brain becomes shrunken from nerve cell loss and advances over 5 to 15 years to a chronic vegetative state. Progressive cognitive, psychological, and social dysfunction has a profound effect on family and friends. Alzheimer’s disease is associated with significant morbidity, and it may be the fourth leading cause of death in the United States (Katzman 1976). D. K. Kay and colleagues (1964) showed the average survival for demented men to be 2.6 years after the diagnosis of illness, whereas the survival period for nondemented men of the same age was 8.7 years. However, there is great variability in survival statistics from different studies.
Although Alzheimer’s disease is the leading cause of dementia, its etiology remains unknown, and treatment is supportive. The illness is a major problem among the elderly. Approximately 4 percent of the population over the age of 65 is affected, and by age 80, prevalence reaches 20 percent (Brodie 1982). As the elderly population of the United States increases, the number of persons with Alzheimer-type dementia will also increase. Alzheimer’s disease exists in the presenium, but it has been difficult to document a bimodal distribution with regard to age. Even though pathological changes in presenile and senile forms of the illness are similar, there is evidence that early- and late-onset Alzheimer-type dementia differ clinically (Seltzer and Sherwin 1983).
- Type
- Chapter
- Information
- The Cambridge World History of Human Disease , pp. 561 - 568Publisher: Cambridge University PressPrint publication year: 1993
References
, et al. 1987. Histopathological criteria for progressive dementia disorders: Clinical pathological correlation and classification by multivariate data analysis. Ada Neuropathologica 74.Google ScholarPubMed
, , and . 1974. The subcortical dementia of progressive supranuclear palsy. Journal of Neurology, Neurosurgery and Psychiatry 37.CrossRefGoogle ScholarPubMed
, et al. 1984. CT density numbers in patients with senile dementia of the Alzheimer type. Archives of Neurology 41.Google Scholar
, et al. 1982. The cholinergic hypothesis of geriatric memory dysfunction. Science 217.CrossRefGoogle ScholarPubMed
1987. The history of Alzheimer’s disease: The debates. Journal of the History of Medicine and Allied Sciences 42.CrossRefGoogle ScholarPubMed
, , and . 1968. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. British Journal of Psychiatry 114.CrossRefGoogle ScholarPubMed
1982. An epidemiologist views senile dementia facts and fragments. American Journal of Epidemiology 115.Google Scholar
, et al. 1981. Physostigmine and arecoline: Effects of intravenous infusions in Alzheimer presenile dementia. British Journal of Psychiatry 138.CrossRefGoogle ScholarPubMed
, and . 1976. Brain acetylcholine: Control by dietary choline. Science 191.CrossRefGoogle ScholarPubMed
, et al. 1979. Studies in aging of the brain: IV. Familial Alzheimer disease: relation of transmissible dementia, aneuploidy, and microtubular defects. Neurology 29.CrossRefGoogle ScholarPubMed
, , and . 1983. Alzheimer’s disease: A disorder of central cholinergic innervation. Science 219.CrossRefGoogle Scholar
, , and . 1988. Psychosis, behavioral disturbance, and the use of neuroleptics in dementia. Comprehensive Psychiatry 29.CrossRefGoogle ScholarPubMed
, and . 1981. Management of the patient and family coping with dementing illness. Journal of Family Practice 12.Google ScholarPubMed
, , and . 1975. Mini-mental state: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 12.Google ScholarPubMed
, , and . 1975. Use of computerized tomography in senile dementia. Journal of Neurology, Neurosurgery and Psychiatry 38.CrossRefGoogle ScholarPubMed
, and . 1982. Differential diagnosis of presenile dementia on clinical grounds. Acta Psychiatrica Scandinavica 65.CrossRefGoogle ScholarPubMed
1975. EEG evaluation of the patient with dementia. In Psychiatric aspects of neurologic disease, ed. and . New York.Google Scholar
, et al. 1986. Neocortical metabolic abnormalities precede nonmemory cognitive defects in early Alzheimer’s-type dementia. Archives of Neurology 43.CrossRefGoogle ScholarPubMed
1979. Development and application of the extended scale for dementia. Journal of the American Geriatrics Society 27.CrossRefGoogle ScholarPubMed
, and . 1966. The genetics of Alzheimer’s disease: Associations with hematologic malignancy and Down’s syndrome. Archives of General Psychiatry 34.Google Scholar
, et al. 1982. A new clinical scale for the staging of dementia. British Journal of Psychiatry 140.CrossRefGoogle Scholar
, et al. 1987. Comparison of magnetic resonance and roentgen ray computed tomography in dementia. Archives of Neurology 44.CrossRefGoogle ScholarPubMed
, et al. 1988. Single photon emission computed tomography in Alzheimer’s disease: Abnormal iofetamine I123 uptake reflects dementia severity. Archives of Neurology 45.CrossRefGoogle Scholar
1976. The prevalence in malignancy of Alzheimer’s disease: A major killer (editorial). Archives of General Psychiatry 33.Google Scholar
, , and . 1964. Old age mental disorders in Newcastle-upon-Tyne. British Journal of Psychiatry 110.Google ScholarPubMed
, et al. 1981. Instrumental neutron activation analysis of brain aluminum in Alzheimer’s disease and aging. Annals of Neurology 10.Google ScholarPubMed
, and . 1976. Dementia in Parkinson’s Disease. Acta Neurologica Scandinavica 54.CrossRefGoogle ScholarPubMed
, , and . 1985. Clinical heterogeneity in patients with dementia of the Alzheimer type: Evidence for subgroups. Neurology 35.CrossRefGoogle ScholarPubMed
, et al. 1984. Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS–ADRDA ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology 34.CrossRefGoogle ScholarPubMed
, et al. 1988. Consortium to establish a registry for Alzheimer’s disease. Psychopharmacology Bulletin 24.Google ScholarPubMed
, et al. 1953. The electroencephalogram in the senile psychosis. Electroencephalography and Clinical Neurophysiology 6.Google Scholar
1988. Quantitative EEG: II. Frequency analysis and topographic mapping in clinical settings. Journal of Clinical Neurophysiology 5.Google ScholarPubMed
1988. Science and medicine in the spotlight: Alzheimer’s disease as an example. Perspectives in Biology and Medicine 31.CrossRefGoogle ScholarPubMed
, et al. 1982. The Global Deterioration Scale (GDS): An instrument for the assessment of primary degenerative dementia. American Journal of Psychiatry 139.Google Scholar
, et al. 1983. The Brief Cognitive Rating Scale (BCRS): Findings in primary degenerative dementia. Psychopharmacology Bulletin 19.Google Scholar
, et al. 1983. Electroencephalographic sleep aging, and psychopathology: New data and state of art. Biological Psychiatry 18.Google Scholar
, , and . 1972. Rating scales for geriatric psychopharmacology – a review. Psychopharmacology Bulletin 8.Google ScholarPubMed
, , and . 1982. An overview of current concepts of Alzheimer’s disease. American Journal of Psychiatry 139.Google Scholar
, and . 1983. A comparison of clinical features in early and late-onset primary degenerative dementia: One entity or two? Archives of Neurology 40.CrossRefGoogle ScholarPubMed
, et al. 1986. Application of iodine-I123 labeled isopropylamphetamine imaging to the study of dementia. Journal of Nuclear Medicine 27.Google Scholar
, and . 1984. Alzheimer’s disease brain: Alterations in RNA levels and in a ribonuclease–inhibitor complex. Science 225.Google Scholar
, and . 1982. Does the dexamethasone suppression test distinguish dementia from depression? American Journal of Psychiatry 139.Google Scholar
, et al. 1987. The genetic defect causing familial Alzheimer’s disease maps on chromosome 21. Science 235.CrossRefGoogle ScholarPubMed
, , and . 1988. Long-term administration of oral physostigmine in Alzheimer’s disease. Neurology 38.CrossRefGoogle ScholarPubMed
, et al. 1986. Oral tetrahydroaminoacridine in long-term treatment of senile dementia Alzheimer’s disease. New England Journal of Medicine 315.CrossRefGoogle Scholar
, et al. 1981. Some morphometric aspects of the brain in senile dementia of the Alzheimer type. Annals of Neurology 10.CrossRefGoogle ScholarPubMed
, et al. 1983. Oral physostigmine and lecithin improve memory in Alzheimer’s disease. Annals of Neurology 13.CrossRefGoogle Scholar
, et al. 1988. The NINCDS–ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer’s disease: A clinicopathologic study of 57 cases. Neurology 38.CrossRefGoogle ScholarPubMed
, , and . 1968. Observations on the brains of non-demented old people. Journal of the Neurological Sciences 7.Google Scholar
, , and . 1970. Observations on the brains of demented old people. Journal of the Neurological Sciences 11.Google Scholar
, and . 1989. Alzheimer’s disease: A brief history. Journal of the Tennessee Medical Association 82.Google ScholarPubMed
, et al. 1976. Visual evoked response in senile and presenile dementia. Electroencephalography and Clinical Neurophysiology 40.CrossRefGoogle ScholarPubMed
, and . 1985. Pharmacologic management of Alzheimer-type dementia. American Family Physician 32.Google ScholarPubMed
, , and . 1981. The significance of antineuronal antibodies in Alzheimer’s disease. Journal of Neuroimmunology 1.CrossRefGoogle Scholar
, and . 1984. Clinical trials with the cholinergic drug RS86 in Alzheimer’s disease (AD) and senile dementia of the Alzheimer’s type (SDAT). Psychopharmacology 84.CrossRefGoogle Scholar
1978. Possible viral etiology of neurofibrillary changes and neuritic plagues. In Alzheimer’s disease: senile dementia and related disorders, ed. , , and . New York.Google Scholar
, , and . 1977. Lecithin consumption raises serum free-choline levels. Lancet 2.Google ScholarPubMed